← Back to Search

Virtual Reality Visual Field Testing for Eye Diseases

N/A

Recruiting

Led By Sharon F Freedman, MD

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up one month, 1-2 tests per week

Awards & highlights

Study Summary

This trial is testing a new way of measuring the peripheral vision, which is called the VisuALL, as compared to the standard way, which is called the Humphrey Visual Field test. The study will recruit children and young adults who have eye conditions which require visual field testing as part of their standard care. The test does not touch the eyes or require any eye drops to be given, and there is no known risk associated with the test itself. There may be a risk of loss of confidentiality. Participating in this study will require approximately 30 minutes, has no extra cost associated with it, and will be compensated by a parking pass for the day

Who is the study for?

This trial is for children and young adults up to 21 years old with eye diseases affecting peripheral vision. Participants must be cognitively normal, able to understand English, and tolerate wearing virtual reality goggles. Consent from a parent or guardian is required.Check my eligibility

What is being tested?

The study tests VisuALL, an FDA-approved virtual reality system for visual field testing, against the standard Humphrey Visual Field test. It aims to see if this new method can effectively measure peripheral vision in a more convenient way.See study design

What are the potential side effects?

There are no known risks directly associated with the VisuALL test itself; however, there's a potential risk of loss of confidentiality due to participation in the study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ one month, 1-2 tests per week

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~one month, 1-2 tests per week

This trial's timeline: 3 weeks for screening, Varies for treatment, and one month, 1-2 tests per week for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Mean deviation results of visual field parameters

Pattern standard deviation results of visual field parameters

Sensitivity results of visual field parameters

Secondary outcome measures

Percent of participants stating satisfaction as measured by questionnaire

Percent of patients able to use VisuALL home testing as measured by device reading

Percent of patients able to use VisuALL in-office testing as measured by patient observation

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: Patient (pathology) groupExperimental Treatment2 Interventions

This group will perform both the standard of care Humphrey Visual Field (HVF) and the VisuALL Virtual Reality Visual Field.

Group II: Control groupExperimental Treatment1 Intervention

This group will only perform the VisuALL Virtual Reality Visual Field.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor

2,363 Previous Clinical Trials

3,419,986 Total Patients Enrolled

Sharon F Freedman, MDPrincipal InvestigatorDuke University

Media Library

Visual Field Test Clinical Trial Eligibility Overview. Trial Name: NCT05150197 — N/A

Peripheral Visual Field Defect Research Study Groups: Patient (pathology) group, Control group

Peripheral Visual Field Defect Clinical Trial 2023: Visual Field Test Highlights & Side Effects. Trial Name: NCT05150197 — N/A

Visual Field Test 2023 Treatment Timeline for Medical Study. Trial Name: NCT05150197 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the scope of participation for this clinical trial?

"Affirmative. The clinicaltrials.gov portal reveals that this investigation is actively enrolling subjects, with the original post published on January 19th 2022 and most recent update occurring July 22nd of the same year. To reach completion, 500 individuals must be recruited from a single medical centre."

Answered by AI

What are the parameters for inclusion in this clinical trial?

"This trial is enrolling 500 individuals aged 4 to 21 that currently experience visual field defect, peripheral. Further criteria for participation include the capacity to wear virtual reality goggles for 10 minutes and being under 18 at the time of diagnosis (or over 18 but diagnosed prior to turning 18). Additionally, any ocular disease which could interfere with testing must be absent from applicants."

Answered by AI

Is the age requirement for this study greater than 18 years?

"Patients eligible for this trial must be between 4 and 21 years of age. In addition, there are 16 trials open to minors and 94 studies available for people over the age of 65."

Answered by AI

Are there any vacant positions available in this trial for participants?

"Clinicaltrials.gov displays that this medical study is presently enrolling qualified individuals. This trial was first published on the 19th of January 2022 and latest modified as recent as the 22nd of July 2022."

Answered by AI

Recent research and studies

Translational Vision Science & TechnologyJournal

A Virtual Reality-based Automated Perimeter, Device, and Pilot Study

Montelongo, Mario, Alberto Gonzalez, Freddy Morgenstern, Sean P. Donahue, and Sylvia L. Groth. 2021. “A Virtual Reality-based Automated Perimeter, Device, and Pilot Study”. Translational Vision Science & Technology. Association for Research in Vision and Ophthalmology (ARVO). doi:10.1167/tvst.10.3.20.

Journal of GlaucomaJournal

Preliminary Report on a Novel Virtual Reality Perimeter Compared with Standard Automated Perimetry

Razeghinejad, Reza, Alberto Gonzalez-Garcia, Jonathan S. Myers, and L. Jay Katz. 2020. “Preliminary Report on a Novel Virtual Reality Perimeter Compared with Standard Automated Perimetry”. Journal of Glaucoma. Ovid Technologies (Wolters Kluwer Health). doi:10.1097/ijg.0000000000001670.

clinicaltrials.govStudy

Virtual Reality Visual Field Testing as an Alternative in Childhood Eye Disease

2022. "Virtual Reality Visual Field Testing as an Alternative in Childhood Eye Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05150197.